Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/30/23
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 07/30/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 08/30/23
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis | NCT05962762 | Asia Cell Therapeutics (Shanghai) Co., Ltd. | user2@example.com | None | 2023-08-30 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis | NCT05948982 | Asia Cell Therapeutics (Shanghai) Co., Ltd. | user2@example.com | None | 2023-07-30 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Respiratory Distress Syndrome | NCT05983627 | Asia Cell Therapeutics (Shanghai) Co., Ltd. | user2@example.com | None | 2023-08-30 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |